Background
Chronic diseases are a major current health problem and burden on the health system of many countries. If interventions are not developed and applied at the governmental level, the burden of chronic diseases will continue to increase in the Australian community. These diseases directly affect not only people with the diseases but other individuals in their near environment. In Australia, these chronic diseases include but are not exclusive: ischemic heart disease (IHD), chronic obstructive pulmonary disease (COPD), asthma, diabetes type 2, hypertension and chronic kidney disease (CKD) 1, 2 .
CKD is a result of a decreased filtration function of the kidney, which could have different causes.
To describe the severity of the decreased renal function CKD is divided into five different stages depending on the estimated glomerular filtration rate (eGFR) see Table 1 below. Using serum creatinine and a predictive equation does this estimation. The definition of the stages and the progression between them has been developed from the kidney disease outcomes quality initiative (K/DOQI) 3 . An important factor that should be considered is that not all patients with CKD will develop end stage kidney disease (ESKD). ESKD indicates that the person will need renal replacement therapy (RRT) either as organ transplantation or as some form of dialysis treatment such as hemodialysis (HD) or peritoneal dialysis (PD). This review will focus on the care of adult patients with pre-dialysis CKD stage 1-4.
From a worldwide perspective the numbers of patients with CKD is rising and could, over the next decade, reach epidemic proportions 4 . The Australian Institute of Health and Welfare (AIHW) report that 7.5% of the Australian population aged 25 and over may have reduced kidney function 5 . Other Australian research, performed in 2000, showed that 11.4% of the non-institutionalised population had CKD stage 3 to 5 6 . This study utilised various indicators of kidney damage, such as proteinuria, hematuria and eGFR. Other commonly used indicators to measure renal health are described in Table 2 . One specific and important difference in the care for ESKD population compared to groups with other chronic kidney disease is the high cost for the health system and society of dialysis treatment 7 . For that reason one important aim of the care of patients with CKD is how to effectively delay or prevent progression of their decrease in renal function and as a result the need for dialysis as RRT.
In Queensland, goals of the statewide chronic disease strategy are the improvement in Quality of Life (QoL) for people with chronic disease and reduction in the number of hospital admissions of patients with chronic diseases. These goals are in line with the national goals for CKD care stated by AIHW 5 One way to reach these goals is by implementation of evidence based strategies as well as reducing the age-standardised incidence and prevalence rates of the chronic disease. The strategy aims to reduce underlying lifestyle and behavioural risk factors 8 .
CKD has been described as one of an epidemic of chronic disease and like most chronic diseases, CKD responds well to early intervention. Recent research has shown that interventions during early stages of CKD will reduce both morbidity and mortality. One step to reach a higher degree of early detection and better case management has lead to Queensland Health planning to increase and expand multidisciplinary programs 7 .
In Australia today, the care of patients with CKD is mostly provided in a traditional medical model of care, which is further described below. In some other countries, care is provided through a multidisciplinary team model also further described below. This multidisciplinary model of care is now being trialled in Australia 7 .
In the Australian health system, general practitioners (GP's) are the first line professional caregivers for people with CKD in the earlier stages (1 or 2). The GP is mostly working in a traditional medical model where the GP is the primary treating professional, referring to and receiving feed back from other health professionals. Often there is limited communication between different health care workers. The main focus is on the patients' physical problems and there is less focus on the patients' other needs. After progression to stage 3, the patient should be referred to a nephrologist, at least for consultation. During 2003 to 2004 people with CKD were managed by GPs at a rate of three per 1000 encounters 5 . A multi centre study performed in Italy during 2003, including 312 GPs and 451,548 study participants [9] , showed approximately the same frequency as in Australia. One aim of the traditional medical treatment model is to monitor specific treatment targets in areas, which are well known to be predictors for CKD. Treatment targets are often set for hypertension, weight, blood glucose and dyslipidaemia. Ways to reach the targets are by diet and exercise, control of proteinuria and medications 4 . The traditional medical model of care is exclusively physician led with very little input from other healthcare providers which makes the care less multidimensional 10 .
Traditional renal care for patients with CDK (stage 3 or higher) is based on established methods of medical treatment models, with care usually provided by nephrologists, consultants or registrars. The patients with CKD will have an appointment with a physician and the frequency of appointment is decided by the patient's medical severity, that is their CKD stage. In the public health system, there is no guarantee that they will meet the same physician every time, which may have a negative impact on the continuity of the care and the relationship between patient and the physician 11 .
In contrast to the traditional medical model of care, a multidisciplinary team model is configured to individualise the care to cover necessary areas in order to reach a higher wellbeing, Quality of Life (QoL), for the patient as well as delay or prevent progression of their CKD. The main role of this multidisciplinary team is to implement and work with lifestyle interventions for patients with the aim of increasing the patients' wellbeing. Different members of the team communicate with each other and with the care coordinator. It is also common with team meetings where patients need are being discussed from different perspectives. Professions commonly found in the team include exercise physiologists or physiotherapists whose focus is exercise and physical activities, dieticians who provide advice and education about nutrition, diet and eating habits, social workers and/or clinical psychologists who in a counselling role have focus on motivation and support for the development of self management strategies. Other professions that can be included are pharmacists, occupational therapists, diabetes educators and podiatrists 12 .
Nurses are key team members often acting as care coordinator/case manager in the multidisciplinary team and in particular nurse practitioners (NP) have demonstrated positive effects on outcomes for patients with chronic diseases 13 . These include decreased levels of HbA 1c for patients with diabetes 14 , lower diastolic blood pressure for patients with hypertension 15 , reduction in hospitalisation for patients with heart failure 16 . The literature also describes positive effects in a renal context of using NPs experienced in renal care -instead of rotating registrars. The NPs are more likely to adhere to guidelines with positive outcomes for the patient 17 .
One major difference in the care provided as NP led care compared to GP/physician led care is the educational component. NPs spend more time on the education of their patients including explaining and answering medical questions about their disease and treatment 18 . Currently all published research relating to the care provided by NPs and multidisciplinary teams is international.
In most studies there is an assumption that each patient has a healthcare provider who coordinates their care. This provider could be a physician, a GP, a NP or another medical subspecialist 10, 19 . Horrocks (2002) states that NPs know how to provide care of the same quality and safety as physicians and are therefore most suitable to lead and coordinate the care, which is provided by a multidisciplinary team 20 .
Objectives
The objective for this systematic review is to compare the effectiveness of a multidisciplinary team care model on the progression of CKD by pre-dialysis adult patients in comparison to the model of traditional medical care. The review will explore clinical outcomes measuring renal function as well as patients' wellbeing measured as QoL.
Criteria for considering studies for this review

Types of studies
To evaluate the effectiveness of multidisciplinary care for patients with pre dialysis CKD, primarily randomised controlled trials (RCT) studies that compare renal function and/or QoL by patients receiving traditional medical care or multidisciplinary care will be utilised for the systematic review. In the absence of RCTs, other designs such as quasi-randomised controlled studies, case control or descriptive studies will be considered. Only English language studies will be considered for inclusion in this systematic review as a result of resource limitations, which prohibit translation of papers from other languages.
Types of participants
Inclusion criteria for the participants are: adults between 18 and 70 years of age; pre-dialysis CKD, not institutionalised in hospital or other care settings. Comorbidities such as diabetes, cardiovascular diseases, hypertension or other common comorbidities are acceptable for inclusion along with pharmacological treatment for these. Participants have to have received either traditional medical care or multidisciplinary care for example at specific CKD-clinics.
Types of interventions
Studies will be considered for inclusion in the review if they compare or describe multidisciplinary care and traditional medical care of patients with pre-dialysis CKD. The studies should include one or more of following interventions:
 Non-pharmacological interventions for example self-management, motivational support and lifestyle change such as dietary changes, physical activity and/or exercise.
 Pharmacological interventions with the aim to keep hypertension, weight and blood glucose at treatment targets as a way to delay or prevent progression of CKD with the aim to improve clinical data but also increase QoL for participants.
Types of outcome measures
Effect on outcomes as a result from the model of care, either medical or multidisciplinary, for patients with pre-dialysis CKD, are usually measured as signs of their renal function along with their wellbeing (QoL). The primary outcomes to be measured are: 
Search strategy for identification of studies
The search strategy aims to identify both English language published and unpublished studies from 1990 to 2008. A three-step strategy will be followed, in which the initial phase will consist of searches of the CINAHL, MEDLINE and PsycINFO databases using keywords or terms. Second, a more extensive search will be performed using the appropriate Subject Headings and/or keywords/phrase/strategy for each of the databases listed below. Finally, the reference lists or bibliographies of identified reports and articles will be hand searched for additional relevant studies. All studies identified during the database search will be assessed for relevance to the review based on the information provided in the title and the abstract. A full copy of the article will be retrieved for all studies that meet the inclusion criteria. Studies identified by study title from reference list searches will be assessed for relevance based on their abstract and if suitable the full article will be retrieved.
Methods of the review
Assessment of methodological quality
Papers selected for retrieval will be assessed independently by two reviewers for methodological quality prior to inclusion in the review. In the assessment process a standardised appraisal instrument, the Joanna Briggs Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix I) will be used. If disagreement occurs between the two reviewers this will be discussed, and if need be resolved, by the third reviewer.
Data extraction
Quantitative data will be extracted from the included papers by using the standardised data extraction tool from JBI-MAStARI (Appendix II). Extracted data will include details about the population, interventions, study methods and outcomes of significance to the objectives of the review.
Data synthesis
Where possible, odds ratio (for categorical outcome data) or standardised mean differences (for continuous data) and their 95% confidence intervals will be calculated for each included study. If appropriate with available data, results from comparable groups of studies will be pooled in statistical meta-analysis using Review Manager 5 (RevMan5) software from the Cochrane Collaboration 21 . Heterogeneity between combined studies will be tested using Chi-square test. Where statistical pooling is not appropriate or possible, the findings will be summarised in narrative form. 
